نتایج جستجو برای: delayed release

تعداد نتایج: 311337  

2012

-----------------------------DRUG INTERACTIONS--------------------------­ • Atazanavir: Do not co-administer with atazanavir. (7.1) • Drugs with pH-Dependent Absorption: May interfere with the absorption of drugs where gastric pH is important for bioavailability. (7.1) • Warfarin: Concomitant warfarin use may require monitoring for increases in INR and prothrombin time. (7.2) • Tacrolimus: Conc...

2009

_____________________________________________________ HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use NEXIUM safely and effectively. See full prescribing information for NEXIUM. NEXIUM (esomeprazole magnesium) DELAYED-RELEASE CAPSULES NEXIUM (esomeprazole magnesium) FOR DELAYED-RELEASE ORAL SUSPENSION INITIAL US APPROVAL: 1989 (omeprazole)...

2009

DESCRIPTION The active ingredient in PROTONIX (pantoprazole sodium) Delayed-Release Tablets and PROTONIX (pantoprazole sodium) For Delayed-Release Oral Suspension is a substituted benzimidazole, sodium 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl] sulfinyl]1H-benzimidazole sesquihydrate, a compound that inhibits gastric acid secretion. Its empirical formula is C16H14F2N3NaO4S x 1.5...

2015
Ralf Gold Gavin Giovannoni J Theodore Phillips Robert J Fox Annie Zhang Leslie Meltzer Nuwan C Kurukulasuriya

BACKGROUND Delayed-release dimethyl fumarate (DMF) demonstrated efficacy and safety in the Phase 3 DEFINE and CONFIRM trials. OBJECTIVE To evaluate delayed-release DMF in newly diagnosed relapsing-remitting multiple sclerosis (RRMS) patients, in a post-hoc analysis of integrated data from DEFINE and CONFIRM. METHODS Patients included in the analysis were diagnosed with RRMS within 1 year pr...

Journal: :Acta poloniae pharmaceutica 2015
Michael A Odeniyi Nasir H Khan Kok K Peh

The delayed release and mucoadhesive properties of Cedrela gum and hydroxypropylmethylcellulose blend in diclofenac sodium tablet formulations were evaluated. Tablets were prepared by direct compression and the crushing strength and detachment force were found to increase from 74.49 ± 1.22 to 147.25 ± 2.57 N and 0.302 ± 0.36 to 1.141 ± 0.05 N from low to high level of polymers, respectively. Th...

2013
QUAN ZHANG YE ZHANG WENJUN CHEN BINGWEN ZHANG SHILONG WANG

The aim of this study was to investigate the ability of mesoporous bioactive glass with ordered nanopores (80S MBG) to adsorb and provide the delayed release of 125I-tagged bone morphogenetic protein-2 (BMP-2). A 50 mg piece of 80S MBG was produced, which comprised SiO2, CaO and P2O5 in a component molar ratio of 80:15:5. Each MBG piece adsorbed 30 μg 125I-BMP-2. Persistent radioactivity in the...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 1986
I S Cohen W Van der Kloot

Facilitation and delayed spontaneous release were recorded from neuromuscular junctions at 2 temperatures. In some experiments, Sr2+ substituted for Ca2+. We measured the ratio of delayed release to resting spontaneous release (D), and the ratio of the second end-plate potential amplitude to the first (F). An extension of the model of Barton et al. (1983) relating Ca2+ to evoked and spontaneous...

Journal: :Diabetes care 2018
Daniela Fangmann Eva-Maria Theismann Kathrin Türk Dominik M Schulte Isabelle Relling Katharina Hartmann Julia K Keppler Jörg-Rainer Knipp Ateequr Rehman Femke-Anouska Heinsen Andre Franke Lennart Lenk Sandra Freitag-Wolf Esther Appel Stanislav Gorb Charles Brenner Dirk Seegert Georg H Waetzig Philip Rosenstiel Stefan Schreiber Karin Schwarz Matthias Laudes

OBJECTIVE Gut microbiota represent a potential novel target for future prediabetes and type 2 diabetes therapies. In that respect, niacin has been shown to beneficially affect the host-microbiome interaction in rodent models. RESEARCH DESIGN AND METHODS We characterized more than 500 human subjects with different metabolic phenotypes regarding their niacin (nicotinic acid [NA] and nicotinamid...

2008

Dual Therapy: PREVACID Amoxicillin 30 mg 1 gram Three times daily for 14 days Benign Gastric Ulcer Short-Term Treatment (1.4) 30 mg Once daily up to 8 wks NSAID-associated Gastric Ulcer (1.6) Healing Risk Reduction 30 mg 15 mg Once daily for 8 wks Once daily up to 12 wks GERD (1.7) Short-Term Treatment of Symptomatic GERD 15 mg Once daily up to 8 wks Short-Term Treatment of EE 30 mg Once daily ...

Journal: :Antimicrobial Agents and Chemotherapy 2019

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید